title: [Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
abstract: Parathyroid carcinoma is a rare cause of hyperparathyroidism and metabolic osteopathy. The authors report a patient with parathyroid carcinoma who underwent 99mTc-Sestamibi parathyroid and 99mTc-MDP bone scanning. These techniques showed the parathyroid lesion and typical features of severe metabolic osteopathy respectively. The bone scan performed at only four months after surgery showed near complete resolution.
authors.affiliation: Servicio de Medicina Nuclear. Hospital San Juan. Alicante.
authors.forename: J
authors.initials: J
authors.lastname: Serrano
authors.forename: J
authors.initials: J
authors.lastname: Verdú
authors.forename: A
authors.initials: A
authors.lastname: Martínez
authors.forename: A
authors.initials: A
authors.lastname: Antón
authors.forename: O
authors.initials: O
authors.lastname: Caballero
mesh_terms: D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging / Q000209:etiology*; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002277:Carcinoma / Q000150:complications* / Q000000981:diagnostic imaging / Q000601:surgery; D003287:Contrast Media; D005500:Follow-Up Studies; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000601:surgery; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives; D017256:Technetium Tc 99m Sestamibi; D013997:Time Factors
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D017256:Technetium Tc 99m Sestamibi; D013669:Technetium Tc 99m Medronate
vernacular_title: Osteopatía metabólica hiperparatiroidea reversible, secondaria a carcinoma de paratiroides.